Apr 4, 2011 | Digital Pathology, Laboratory News, Laboratory Pathology
Experts at National Comprehensive Cancer Network conference voice opinions It may surprise many pathologists and clinical laboratory managers to learn that a number of prominent healthcare leaders recently voiced significant reservations about the current status of molecular genetics testing. In their view, clinical pathology laboratory testing that incorporates genetic and molecular technologies needs further refinement, improved billing codes, and additional regulation before it can fulfill...
